Results 171 to 180 of about 190,847 (266)
FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook. [PDF]
Moriyama H, Moriyama S, Yokota T.
europepmc +1 more source
Adjuvant visible incoherent polarised phototherapy in chronic skin defects: a single-arm prospective observational cohort study. [PDF]
Trnka M +3 more
europepmc +1 more source
ABSTRACT In this study, the possibility of using aquafaba powder, derived from chickpea cooking water, as a natural emulsifier in the formulation of plant‐based coffee whitener was evaluated. For this purpose, coffee whiteners, which are emulsion type products, are obtained by high‐shear mixing followed by high‐pressure homogenization of the aqueous ...
Sinem Ece Bekdemir, Cansu Ekin Bonacina
wiley +1 more source
Highlights in IO: next-generation CAR-T therapy for glioblastoma. [PDF]
Yamaguchi J, Okada H.
europepmc +1 more source
A new musculoskeletal reconstruction and revision of the cranio‐mandibular anatomy of the Devonian arthrodire placoderm Dunkleosteus terrelli from a comparative and functional anatomical perspective. Dunkleosteus is a specialized arthrodire with many specializations for feeding on large vertebrates, and many of its features are part of broader ...
Russell K. Engelman +4 more
wiley +1 more source
New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9. [PDF]
Arnaboldi L, Tang Z, Ferri N, Corsini A.
europepmc +1 more source
This review critically evaluates clotrimazole as a potential antifungal for finfish aquaculture, highlighting strong mechanistic and in vitro efficacy against aquatic mycoses alongside major gaps in in vivo evidence, toxicokinetics, residue safety, and environmental risk, outlining priorities for responsible therapeutic development and regulatory ...
Arya Sen +2 more
wiley +1 more source
Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial. [PDF]
Kølner-Augustson L +7 more
europepmc +1 more source
Advancing rehabilitation in Parkinson's disease through virtual reality: a narrative review. [PDF]
Diotaiuti P +6 more
europepmc +1 more source
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia +16 more
wiley +1 more source

